News
Learn why St. Luke’s DNA Answers has already completed more than 30,000 genetic screenings to find predisposition for genetic ...
Defining "value" in cancer care goes beyond survival and should encompass patient quality of life metrics, said Coral Omene, MD, PhD, of Robert Wood Johnson Medical School.
World Prostate Cancer Day encourages individuals to receive regular screenings and research their family history.
Real-World Data on Metastatic Lung Cancer: Cost Analyses in Brazil From a Private Insurance Company's Perspective Ovarian cancer remains among the most aggressive tumors with the lowest survival ...
Michele Hoaglund, who bought the store about a decade ago from its founding owners, was diagnosed with ovarian cancer around ...
Experts studying the health risks of talc have prompted the U.S. Food and Drug Administration to reevaluate its presence in ...
CBS Boston on MSN1d
A warning about an earlier outbreak of the Norovirus and a new way to detect ovarian cancerThe legal issues raised by Trump sending the National Guard to L.A. Mystery of America's 'Lost Colony' may finally be solved ...
Retifanlimab-dlwr (Zynyz) was granted approval from the FDA for treatment of locally recurrent or metastatic squamous cell ...
Certain HPV vaccines prevent cancers of the cervix, vulva, vagina, and anus. The time to get vaccinated is between ages 9 and ...
Primary surgery for advanced ovarian cancer significantly improves progression-free survival but not overall survival ...
Adding relacorilant to nab-paclitaxel improved survival outcomes in patients with platinum-resistant ovarian cancer.
Brian Slomovitz, MD, of Mount Sinai Medical Center, compares relacorilant plus nab-paclitaxel with existing treatments for platinum-resistant ovarian cancer and highlights the ROSELLA trial’s global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results